239 related articles for article (PubMed ID: 10831642)
1. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.
Woodrow G; Oldroyd B; Stables G; Gibson J; Turney JH; Brownjohn AM
Nephrol Dial Transplant; 2000 Jun; 15(6):862-6. PubMed ID: 10831642
[TBL] [Abstract][Full Text] [Related]
2. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.
Woodrow G; Stables G; Oldroyd B; Gibson J; Turney JH; Brownjohn AM
Nephrol Dial Transplant; 1999 Jun; 14(6):1530-5. PubMed ID: 10383020
[TBL] [Abstract][Full Text] [Related]
3. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure, volume, and sodium control in an automated peritoneal dialysis population.
Boudville NC; Cordy P; Millman K; Fairbairn L; Sharma A; Lindsay R; Blake PG
Perit Dial Int; 2007; 27(5):537-43. PubMed ID: 17704444
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
[TBL] [Abstract][Full Text] [Related]
6. Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients.
Cho KH; Do JY; Park JW; Yoon KW
Nephrol Dial Transplant; 2010 Feb; 25(2):593-9. PubMed ID: 19767632
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
8. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
Akonur A; Guest S; Sloand JA; Leypoldt JK
Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
10. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
11. Does peritoneal dialysate affect body composition assessments using multi-frequency bioimpedance in peritoneal dialysis patients?
Davenport A
Eur J Clin Nutr; 2013 Feb; 67(2):223-5. PubMed ID: 23249878
[TBL] [Abstract][Full Text] [Related]
12. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
13. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
[TBL] [Abstract][Full Text] [Related]
14. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis.
Dart A; Feber J; Wong H; Filler G
Pediatr Nephrol; 2005 May; 20(5):683-5. PubMed ID: 15719251
[TBL] [Abstract][Full Text] [Related]
15. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.
Davies SJ; Woodrow G; Donovan K; Plum J; Williams P; Johansson AC; Bosselmann HP; Heimbürger O; Simonsen O; Davenport A; Tranaeus A; Divino Filho JC
J Am Soc Nephrol; 2003 Sep; 14(9):2338-44. PubMed ID: 12937311
[TBL] [Abstract][Full Text] [Related]
16. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
[TBL] [Abstract][Full Text] [Related]
17. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
18. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
[TBL] [Abstract][Full Text] [Related]
19. Calcium and magnesium flux in automated peritoneal dialysis.
Eddington H; Hurst H; Ramli MT; Speake M; Hutchison AJ
Perit Dial Int; 2009; 29(5):536-41. PubMed ID: 19776047
[TBL] [Abstract][Full Text] [Related]
20. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.
Paniagua R; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Orihuela O; Prado-Uribe MD; Alcántara G; Amato D
Perit Dial Int; 2009; 29(4):422-32. PubMed ID: 19602608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
